Evidence map›Paper›PMID 42483120›Full record

ArticleCureus2026

Correlation of Chest Wall Separation and Central Lung Distance With Ipsilateral Lung Dose in Post-operative Breast Cancer Patients Treated With Intensity-Modulated Radiotherapy (IMRT): A Retrospective Study.

Yamini Bisht, Shashank Shekhar, Vishwadeep Mishra, Anjalikrishna Np

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yamini BishtDepartment of Radiotherapy, All India Institute of Medical Sciences Gorakhpur, Gorakhpur, IND.
Shashank ShekharDepartment of Radiotherapy, All India Institute of Medical Sciences Gorakhpur, Gorakhpur, IND.
Vishwadeep MishraDepartment of Radiotherapy, All India Institute of Medical Sciences Gorakhpur, Gorakhpur, IND.
Anjalikrishna NpDepartment of Radiotherapy, All India Institute of Medical Sciences Gorakhpur, Gorakhpur, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Post-operative chest wall radiotherapy with or without regional nodal irradiation is a cornerstone of breast cancer management. With increasing adoption of hypofractionated intensity-modulated radiotherapy (IMRT), minimizing incidental lung irradiation remains important despite improvements in dose conformity. Conventional geometric surrogates such as central lung distance (CLD) and chest wall separation (CWS), widely used in two-dimensional (2D) and three-dimensional (3D) conformal radiotherapy, have been less extensively evaluated in the IMRT era. This study assessed the relationship between these geometric parameters and ipsilateral lung dose in post-operative breast cancer patients treated with hypofractionated IMRT. Methods Thirty-six post-operative breast cancer patients treated at the Department of Radiotherapy, All India Institute of Medical Sciences (AIIMS), Gorakhpur, India, were retrospectively analysed. Twenty-eight patients (77.8%) had right-sided disease and eight (22.2%) had left-sided disease. All patients received hypofractionated IMRT to the chest wall with or without supraclavicular fossa irradiation to a dose of 40 Gy in 15 fractions. CWS was defined as the tangential distance between the anterior and posterior extents of the contoured chest wall on axial CT images, averaged across three central slices. CLD was measured as the perpendicular distance from the posterior chest wall into the ipsilateral lung. Dosimetric parameters analysed included ipsilateral lung V5, V10, V20, and mean lung dose (MLD). Pearson correlation analysis was used to evaluate associations between geometric and dosimetric parameters. Patients were additionally stratified into two groups based on CWS (<16 cm and ≥16 cm), and intergroup comparisons were performed using a two-tailed independent samples t-test. Results CLD demonstrated significant positive correlations with all evaluated ipsilateral lung dose parameters, with increasing correlation strength from low-dose to higher-dose metrics (percentage lung volume receiving ≥5 Gy (V5): r = 0.445, p = 0.006; percentage lung volume receiving ≥10 Gy (V10): r = 0.500, p = 0.002; percentage lung volume receiving ≥20 Gy (V20): r = 0.579, p < 0.001; MLD: r = 0.592, p < 0.001). CWS showed weaker inverse correlations with lung dose parameters, reaching statistical significance only for lung V20 (r = -0.418, p = 0.011). On subgroup analysis, patients with CWS <16 cm demonstrated significantly higher lung V20 values compared with those with CWS ≥16 cm (29.01 ± 3.13% vs 26.83 ± 0.92%; t = 2.964, p = 0.005). MLD was also higher in the CWS <16 cm group (14.92 ± 0.94 Gy vs 14.13 ± 1.34 Gy), although this difference did not reach statistical significance (t = 1.989, p = 0.055). Conclusion CLD is a significant geometric predictor of ipsilateral lung dose in post-operative breast cancer patients treated with hypofractionated IMRT. Significant associations were observed between CLD and all evaluated lung dose-volume parameters, particularly lung V20 and MLD. CWS demonstrated a weaker but significant inverse association with lung V20. These findings highlight the continued relevance of simple anatomical surrogates in contemporary breast radiotherapy planning and suggest that CLD may serve as a practical indicator of increased lung dose exposure during treatment planning.

Indexed as

breast cancercentral lung distancechest wall separationhypofractionationintensity-modulated radiotherapylung dose–volume parameters

Identifiers

PMID42483120
PMCPMC13387265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.